维普期刊资源整合服务平台（V6.5）

36篇 您的检索式：作者名="WOLFERT RL"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Lp-PLA2:an emerging biomarker of coronary heart disease显示文摘	Dada N Kim NW Wolfert RL	2002	Expert Rev Mol Diagn2002，2，1：	1
2	Evaluation of percentage of free serum prostate-specific antigen to improve specificity of prostate cancer screening 显示文摘	Smith DS Wolfert RL	1995	JAMA1995，274，15：	1
3	Lipoprotein associated phospholipase A (2) : role in atherosclerosis and utility as a bi- omarker for cardiovascular risk 显示文摘	Colley KJ Wolfert RL Cobble ME	2011	EPMA J2011，2，1：	1
4	Evaluation of percentage of free serum prostatespecfic antigen to improve specificity of prostate cancer screening显示文摘	CATALONA WJ SMITH DS WOLFERT RL	1995	Jama1995，274，：	1
5	Relationship of lipoprotein-assoeiated phospholipase Az mass and ac- tivity with incident vascular events among primary pre- vention patients allocated to placebo or to statin therapy: an analysis from the Jupiter trial显示文摘	Ridker PM Macfadyen JG Wolfert RL	2012	Clin Chem2012，58，5：	1
6	Lipoprotein associated phos-pholipase A(2) : role in atherosclerosis and utility as a biomarkerfor cardiovascular risk显示文摘	Colley KJ?Wolfert RL Cobble ME	2011	EPMA J2011，2，1：	1
7	The effect of statin ther- apy on lipoprotein associated phospholipase A2 levels 显示文摘	Abert MA Glynn ILl Wolfert RL	2005	Athero- sclerosis2005，182，1：	1
8	Evaluation of percentage of free serum prostate specific antigen to improve specificity of prostate cancer screening显示文摘	Catalona WJ Mith DS Wolfert RL	1995	J AMA1995，274，：	1
9	Biological variability and specificity of lipoprotein-associated phospholipase A2 (Lp-PLA2),a novel marker of cardiovascular risk显示文摘	Wolfert RL Kim NW Selby RG		0，，02：	1
10	Relationship of lipoprotein associ- ated phospholipase A (2) mass and activity with incident vascular events among primary prevention patients allocated to placebo or to statin therapy: an analysis from the JUPITER trial 显示文摘	Ridker PM MacFadyen JG Wolfert RL et at	2012	Clin Chem2012，58，：	1
11	Evaluation of percentage of free serum prostate-specific antigen to improve specificity of prostate cancer screening显示文摘	Smith DS Wolfert RL	1995	JAMA1995，274，15：	1
12	The effect of statin therapy on lipoprotein associated phospholipase A2 levels显示文摘	Albert MA Glynn RJ Wolfert RL	2005	Atherosclerosis2005，182，1：	1
13	Lipoprotein-associated phospholipase A2 : review and recommendation of a clinical cut point for adults 显示文摘	Lanman RB Wolfert RL Fleming JK	2006	Prevent Cardiol2006，9，3：	1
14	Evaluation of percentage of free serum prostate specific antigen to improve specificity of prostate cancer screening显示文摘	Catalona WJ mith DS Wolfert RL	1995	J AMA1995，274，：	1
15	Lipoprotein associated phospholipase A2 concentration predicts total and cardiovascular mortality independently of established risk factors(The Ludwigshafen Risk and Cardiovascular Health Study)显示文摘	Kleber ME Wolfert RL De Moissl GD et a1	2011	Clin Lab2011，57，9：	1
16	Lipoprotein associated phospholipase A2 concentration predicts total and cardiovascular mortality independently of established risk factors显示文摘	KLEBER ME WOLFERT RL DE MOISSL GD	2011	Clin Lab2011，57，910：	1
17	Evaluation of percentage of free serum prostate specific antigen to improve specificity of prostate cancer screening显示文摘	Catalona WJ Mith DS Wolfert RL	1995	JAMA1995，274，：	1
18	Lipoprotein-associated Phospholipase A2:review and recommendation ofa clinical cutpoint for adults显示文摘	Lanman RB Wolfert RL Fleming JK	2006	Prevent Cardiol2006，9，3：	1
19	Evaluation of percentage of free serum prostate-specific antigen to improve specificity of prostate cancer screening 显示文摘	Catalona WJ Smith DS Wolfert RL	1995	JAMA1995，274，15：	1
20	Evaluation of percentage of free serum prostate specific antigen to improve specificity of prostate cancer screening显示文摘	Catalona WJ Mith DS Wolfert RL	1995	JAMA1995，274，：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示